Name | 4-Amino-1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)-2(1H)-pyrimidinone |
---|---|
Synonyms |
2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)-
4-Amino-1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)-2(1H)-pyrimidinone |
Description | |
---|---|
In Vitro | FF-10502 (FF-10502-01) is a pyrimidine nucleoside antimetabolite that shows growth inhibition of pancreatic cancer cell lines with IC50 of 60-330 nM; FF-10502 is far more potent than gemcitabine in inhibiting DNA polymerase ��, significantly induces concentration-dependent cell death in accordance with enhanced DNA damage in combination with DNA damage inducers (H2O2, cisplatin, and temozolomide); also demonstrates complete tumor growth suppression in in vivo patient-derived xenograft models with gemcitabine-resistant pancreatic cancer cells. |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 516.5±60.0 °C at 760 mmHg |
Molecular Formula | C9H12FN3O3S |
Molecular Weight | 261.273 |
Flash Point | 266.2±32.9 °C |
Exact Mass | 261.058350 |
LogP | -1.73 |
Vapour Pressure | 0.0±3.0 mmHg at 25°C |
Index of Refraction | 1.754 |